Amid a challenging market, Medtronic has gained market share in 60% of its businesses and outperformed the Zacks Medical - Products industry by 4.4%. The company announced a collaboration with GE Healthcare to enhance offerings for Ambulatory Surgery Centers, addressing operational cost challenges. Additionally, Medtronic's projected earnings of $1.57 per share mark a 4.67% increase from last year, underscoring its resilience and commitment to innovation.
“Medtronic · claims share gains in · 60% of its businesses · yes”
“Medtronic · has outperformed · Zacks Medical - Products industry · +4.4% vs. -14.6%”
“Medtronic · claims share gains · in 60% of its businesses”
“Medtronic · has outperformed · Zacks Medical - Products industry · +4.4% vs. -14.6%”
“Medtronic · claims share gains in · 60% of its businesses · true”
“Medtronic · is headquartered in · Dublin, Ireland”
“Medtronic · has a global team of · people · 90,000+”
“Medtronic · treats health conditions including · cardiac devices · 70”
“Medtronic and GE Healthcare · announce · a collaboration · focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs)”
“GE Healthcare and Medtronic · seek to help · ASCs · navigate high costs and complexity”
“Medtronic · continues to offer · reimbursement support and remote solutions”
“Medtronic · is headquartered in · Dublin, Ireland”